Correlation Between Mirati Ther and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both Mirati Ther and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mirati Ther and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mirati Ther and Blueprint Medicines Corp, you can compare the effects of market volatilities on Mirati Ther and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mirati Ther with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mirati Ther and Blueprint Medicines.
Diversification Opportunities for Mirati Ther and Blueprint Medicines
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mirati and Blueprint is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Mirati Ther and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Mirati Ther is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mirati Ther are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Mirati Ther i.e., Mirati Ther and Blueprint Medicines go up and down completely randomly.
Pair Corralation between Mirati Ther and Blueprint Medicines
If you would invest 8,720 in Blueprint Medicines Corp on November 2, 2024 and sell it today you would earn a total of 2,685 from holding Blueprint Medicines Corp or generate 30.79% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 5.26% |
Values | Daily Returns |
Mirati Ther vs. Blueprint Medicines Corp
Performance |
Timeline |
Mirati Ther |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Blueprint Medicines Corp |
Mirati Ther and Blueprint Medicines Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mirati Ther and Blueprint Medicines
The main advantage of trading using opposite Mirati Ther and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mirati Ther position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.Mirati Ther vs. Sarepta Therapeutics | Mirati Ther vs. Krystal Biotech | Mirati Ther vs. Day One Biopharmaceuticals | Mirati Ther vs. Amylyx Pharmaceuticals |
Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |